Neurology
Latest News
NeurologyLive® Friday 5 — August 15, 2025
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending August 15, 2025.
Vormatrigine Reduces Seizures in Phase 2 RADIANT Study, Postpartum Depression in MS Women, Ianalumab Produces Significant Phase 3 Data in Sjögren’s disease
Neurology News Network. for the week ending August 16, 2025. [WATCH TIME: 4 minutes]
Risk Factors and Risk Mitigation Strategies of SUPED for Patients With Dravet Syndrome
Panelists discuss how patients with Dravet syndrome face elevated sudden unexplained death in epilepsy (SUDEP) risk compared with other epilepsy popul...
Addressing Constipation, Sleep, and Fatigue in Parkinson Disease Care: Alexa Dessy, MD
The clinical assistant professor in movement disorders at Jefferson Health outlined a patient-centered, lifestyle-first approach to managing Parkinson...
Standard of Care and Dravet Syndrome–Specific ASMs: Mechanisms and Risk Management
Panelists discuss how the treatment paradigm for Dravet syndrome has dramatically shifted with newer FDA-approved medications (cannabidiol, stiripento...
Phase 2 GABriella Study Represents First Step in Testing Selective Novel Y-Secretase Modulators for Prodromal Alzheimer Disease
Researchers unveil promising findings from the GABriella trial, exploring a novel treatment for prodromal Alzheimer's disease at AAIC 2025.
Evaluating Biomarkers to Guide Personalized Remyelination Strategies in MS: Ahmed Abdelhak, MD
At CMSC 2025, assistant professor of neurology at the University of California, San Francisco discussed progress on the integration of biomarkers into...
Measuring Sleep Duration and Identifying Phenotypes Linked to Cognitive Decline in Hispanic Populations
At AAIC 2025, Alberto Ramos, MD, FAAN, director of the Sleep Disorders program at the University of Miami, discussed the association between long slee...
Target Trial Emulation Favors Rituximab’s Effectiveness Over Cladribine in Treating Multiple Sclerosis
A new study reveals rituximab outperforms cladribine in managing MRI disease activity in relapsing multiple sclerosis over 4.5 years.
Antibiotic Prophylaxis for Upper GI Bleeding in Cirrhosis?
Pooled data show that no or shorter antibiotic prophylaxis for upper GI bleeding in cirrhosis is very likely noninferior to longer courses for all-cau...
NeurologyLive® Friday 5 — August 15, 2025
Risk Factors and Risk Mitigation Strategies of SUPED for Patients With Dravet Syndrome
Addressing Constipation, Sleep, and Fatigue in Parkinson Disease Care: Alexa Dessy, MD
Standard of Care and Dravet Syndrome–Specific ASMs: Mechanisms and Risk Management
Evaluating Biomarkers to Guide Personalized Remyelination Strategies in MS: Ahmed Abdelhak, MD
Measuring Sleep Duration and Identifying Phenotypes Linked to Cognitive Decline in Hispanic Populations
Target Trial Emulation Favors Rituximab’s Effectiveness Over Cladribine in Treating Multiple Sclerosis
Antibiotic Prophylaxis for Upper GI Bleeding in Cirrhosis?
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago